Best thing about is that we have only 16.7 million shares outstanding. 25% insider control .
Look at he volume today it's every day lower since we had that big jump. selling product next year that is going to grow revenue quarter after quarter.
And products that go into clinical trials. Don't think that this one is going to be bought out.
But selling a part pf the company is possible ,and that could be even higher then today's ridiculous market cap